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Major Histocompatibility Complex (MHC) class II mole-
cules, including Human Leukocyte Antigen (HLA)-DR,
present peptide fragments from proteins degraded in
the endocytic pathway. HLA-DR is targeted to late-
endocytic structures named MHC class II-containing
Compartments (MIIC), where it interacts with HLA-DM.
This chaperone stabilizes HLA-DR during peptide ex-
change and is critical for successful peptide loading.
To follow this process in living cells, we have gener-
ated cells containing HLA-DR3/Cyan Fluorescent Pro-
tein (CFP), HLA-DM/Yellow Fluorescent Protein (YFP),
and invariant chain. HLA-DR/DM interactions were ob-
served by Fluorescence Resonance Energy Transfer
(FRET). These interactions were pH insensitive, yet
occurred only in internal structures and not at the
limiting membrane of MIIC. In a cellular model of in-
fection, phagosomes formed a limiting membrane
surrounding internalized Salmonella. HLA-DR and
HLA-DM did not interact in Salmonella-induced vacu-
oles, and HLA-DR was not loaded with antigens. The
absence of HLA-DR/DM interactions at the limiting
membrane prevents local loading of MHC class II
molecules in phagosomes. This may allow these bac-
teria to successfully evade the immune system.
Introduction
Major Histocompatibility Complex (MHC) class II mole-
cules present peptide fragments of antigens degraded
in the endocytic pathway to CD4+ T cells (Bryant et
al., 2002). This is a prerequisite for efficient antibody
responses and the establishment of an effective immu-
nological memory. In order to contact antigens, MHC
class II molecules like Human Leukocyte Antigen (HLA)-
DR (DR) are chaperoned from the endoplasmic reticu-
lum (ER) to late endocytic structures (called MHC class*Correspondence: j.neefjes@nki.nl
3 These authors contributed equally to this work.
4 Present address: Sanquin Research at CLB, Amsterdam, The
Netherlands.
5 Present address: Department of Biological and Biomedical Sci-
ences, University of Durham, Durham, United Kingdom.II containing compartments, or MIIC [Peters et al.,
1991]) by the invariant chain. Here, the invariant chain
is degraded except for a small fragment called CLIP,
which remains in the peptide binding groove of DR
(Cresswell, 1992). HLA-DM (DM), a second dedicated
chaperone, is required to stabilize the “empty” MHC
class II molecules and supports the exchange of both
CLIP and low-affinity peptides for a peptide with high
affinity (Denzin and Cresswell, 1995; Kropshofer et al.,
1997; Sherman et al., 1995) that fills pocket 1 in the
peptide binding groove (Chou and Sadegh-Nasseri,
2000). The direct interaction between DM and DR has
been shown in in vitro reconstitution experiments and
coisolations. This interaction was pH sensitive and of
low affinity (Sanderson et al., 1996; Vogt et al., 1999).
DM interacts with a lateral site on DR via hydrophobic
surfaces, but the exact factors that contribute to this
process remain unclear (Doebele et al., 2000; Pashine
et al., 2003; Ullrich et al., 1997). More recently, a non-
polymorphic MHC class II homolog has been identified,
called HLA-DO (DO). DO stably interacts with DM, re-
ducing its chaperoning activity on DR in a pH-depen-
dent manner (Denzin et al., 1997; Liljedahl et al., 1998;
van Ham et al., 1997). Like the DR/DM complex, the
DM/DO complex is targeted to the MIIC.
MIIC are characterized by a multilamellar and/or
multivesicular structure. Multivesicular bodies (MVB)
can be converted into multilamellar structures by changes
in protein content (Calafat et al., 1994) and both type of
structures most likely reflect different maturation states
(Kleijmeer et al., 1997). The internal structures differ
from the limiting membrane by both protein and lipid
composition. Whereas DR and DM can be found in both
domains, other late-endocytic proteins like tetraspans,
and lipids like cholesterol and lyso-bis-PA, are usually
located at the internal structures (Gruenberg, 2003;
Wubbolts et al., 2003). Although tetraspans like CD63
and CD82 interact with DM or DR (Escola et al., 1998;
Hammond et al., 1998), the functional consequences
are unclear. Still, internal structures differ in composi-
tion from the limiting membrane, and this may affect
the interaction between DR and its chaperone DM and
ultimately antigen presentation (Kropshofer et al.,
2002). The failure to visualize these interactions due to
the limited resolution of light microscopy prevented any
conclusion about spatial specialization within MIIC.
The formation of internal structures that characterize
the morphology of a MVB is the result of a complicated
series of events. It requires the activities of a PI 3-kinase
hVPS34, ESCRT complexes, ubiquitination, and acidifi-
cation (Katzmann et al., 2002). Inhibition of hVPS34 or
acidification results in expanded late-endosomal struc-
tures without internal vesicles (Fernandez-Borja et al.,
1999). Such treatments also affect the MIIC and inhibit
antigen presentation by MHC class II molecules (Mor-
rison et al., 1986; Song et al., 1997). Pathogens like Sal-
monella typhimurium, Mycobacterium tuberculosis,
and Mycobacterium leprae survive in phagosomes
(Brumell and Grinstein, 2004; Russell, 2003), structures
composed of only a limiting membrane surrounding the
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222bacteria. These intracellular bacteria have been re- m
iported to reduce or even eliminate antigen presentation
by MHC class II molecules (Harding et al., 2003; Ra- (
amachandra et al., 2001; Ullrich et al., 2000), but the un-
derlying mechanism remains elusive. D
pHere, we studied the interaction between DM and
DR3 in living cells by Fluorescence Resonance Energy m
wTransfer (FRET). Applying Confocal Laser-Scanning Mi-
croscopy (CLSM)-FRET microscopy allowed us to visu- n
dalize these interactions at unprecedented resolution
within MIIC of living cells. This interaction was not af- p
mfected by neutralization of pH, and it occurred exclu-
sively in the internal structures of MIIC. No interac- m
Dtion was observed in MIIC devoid of internal structures
after long-term chloroquine treatment or knockdown of b
hVPS34. Similarly, phagosomes in which many intracel-
lular pathogens survive often lack internal membranes. w
lThis can occur when hVPS34 is inactivated (Vergne et
al., 2003), or when a downstream product of hVPS34 s
f(PI(3,5)P2) is hydrolyzed by the Salmonella-secreted
PIP2-phosphatase SopB (Hernandez et al., 2004). We 1
oshow that at the limiting membrane of a Salmonella-
induced phagosome (SCV) DM failed to interact with w
pDR3, again using FRET. Consequently, DR3 was not
loaded with antigens within the SCV while antigen load- d
bing within multivesicular MIIC continued in the infected
cells. Local MHC class II-restricted immune escape of D
nintracellular pathogens like Salmonella appears to be a
consequence of subvesicular structural differences p
Iwithin the MIIC, where HLA-DM interacts with HLA-DR
in MHC class II loading microdomains in the internal m
cstructures, but not at the limiting membrane.
s
vResults
A System to Monitor HLA-DR3 Interaction with DM F
wTo study the interaction between DR and DM, the mole-
cules were tagged with two variants of the Green Fluo- F
crescent Protein (GFP): Cyan Fluorescent Protein (CFP)
attached to the cytoplasmic tail of DR3β and Yellow p
oFluorescent Protein (YFP) linked to the cytoplasmic tail
of DMα. GFP tagging of the DR3β chain has been suc- p
icessfully used before but without measurable effects
on MHC class II behavior (Boes et al., 2002; Wubbolts s
Iet al., 1996). The DMβ chain contains the lysosomal-
targeting information (Marks et al., 1995), therefore the b
dDMα chain was used for YFP tagging. To investigate
whether the various modifications still allowed a pro- a
4ductive interaction between DR3/CFP and DM/YFP, the
DRα and DR3β/CFP chains were stably expressed into (
vHuman Embryonic Kidney (HEK) 293 cells along with
the DMα/YFP and DMβ chains. We generated three cell a
alines: HEK293 cells expressing only DR3/CFP, HEK293
cells expressing DR3/CFP and DM/YFP, and HEK293 m
Tcells expressing DR3/CFP, DM/YFP, and the p30 form
of the invariant chain (Ii). By introducing these chains t
in a nonimmune cell line, DR3/CFP peptide loading
could only be supported by YFP-tagged DM because s
ino endogenous DM was present. First, expression of
the various subunits was confirmed by Western blotting f
w(Figure 1A). Subsequent analysis of the stable cell lines
by Confocal Laser Scanning Microscopy (CLSM) re- c
cvealed that DM/YFP was efficiently targeted to endoso-al structures, whereas DR3/CFP was mainly retained
n the ER unless the invariant chain was coexpressed
Figure S1 in the Supplemental Data available with this
rticle online). In the presence of the invariant chain,
M/YFP and DR3/CFP were both efficiently trans-
orted to endosomal structures containing CD63 as a
arker, and DR3/CFP arrived at the plasma membrane
ith similar efficiency as observed in cells endoge-
ously expressing DR3 (Figures 1B and S2). These en-
osomal compartments had the characteristic mor-
hology of MIIC and were a mixture of multilamellar and
ultivesicular bodies, as shown by immuno-electron
icroscopy (EM) (Figure 1C). Note that DM/YFP and
R3/CFP were both distributed over the limiting mem-
rane and the internal vesicles of the MIIC.
Peptide loading was assayed biochemically. DR3
ith high affinity peptides will not dissociate in SDS-
oading buffer when incubated at room temperature, re-
ulting in slower migration of the so-called compact
orm by SDS-PAGE analysis (Germain and Hendrix,
991; Neefjes and Ploegh, 1992). A substantial amount
f compact DR3/CFP molecules was detected only
hen DM/YFP and the invariant chain were coex-
ressed (Figure 1D). This was confirmed by surface io-
ination and analysis of DR3/CFP for temperature sta-
ility (Figure 1E). DM/YFP supported peptide loading of
R3/CFP, implying that the CFP/YFP modifications did
ot prevent a successful interaction between the two
artners. Since the expression, distribution, MHC class
I loading with peptides, and transport to the plasma
embrane mimicked the situation in antigen presenting
ells, we continued our studies with the HEK293 cells
tably transfected with DR3/CFP, DM/YFP, and the in-
ariant chain.
RET Analyses and the Interaction of HLA-DM
ith HLA-DR3 or HLA-DO
RET is the radiationless transfer of energy from an ex-
ited donor fluorophore to a suitable acceptor fluoro-
hore, a physical process that depends on spectral
verlap and proper dipole alignment of the two fluoro-
hores. The occurrence of FRET between CFP and YFP
s characterized by a decrease in CFP emission, and
imultaneously sensitized (increased) YFP emission.
mportantly, FRET is extremely sensitive to the distance
etween the fluorophores (its efficiency decays with the
istance to the sixth power) (Förster, 1948). For CFP
nd YFP, the characteristic half-maximum distance is
9–52 Å (Förster radius) with an upper limit of w80 Å
Tsien, 1998). Given the dimensions of GFP and its color
ariants (Ormo et al., 1996), DM (Mosyak et al., 1998),
nd DR3 (Ghosh et al., 1995), FRET between DR3/CFP
nd DM/YFP will only occur when both proteins are no
ore than one molecule in distance apart (Figure 2).
hus, if FRET is observed, DM almost certainly in-
eracts with DR3.
FRET was studied by calculating the sensitized emis-
ion from confocal CFP and YFP images, as described
n depth (van Rheenen et al., 2004). Leakthrough
actors (due to spectral overlap of the fluorophores)
ere calculated from cells expressing histon 2B (H2B)
oupled to CFP or YFP that were cocultured with the
ells under study (see Supplemental Data). No FRET
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223Figure 1. Characterization of the HEK293 Transfectants Expressing HLA-DR3/CFP and HLA-DM/YFP
(A) HEK293 cells expressing DM/YFP, DO/CFP, DR3/CFP, and the invariant chain (Ii) were analyzed by SDS-PAGE and Western blotting with
the antibodies indicated.
(B) Intracellular distribution of DR3/CFP and DM/YFP in Ii-expressing HEK293 cells. Cells were fixed and stained with anti-CD63 antibody,
and the various fluorophores were analyzed as indicated. A strong colocalization between DR3, DM, and CD63 is observed. Inset shows the
selective surface expression of DR3/CFP.
(C) DR3/CFP and DM/YFP localize to multivesicular and multilamellar structures. HEK293 cells expressing DR3/CFP, DM/YFP, and Ii were
fixed and prepared for cryo-immuno-EM. DM (10 nm gold) and DR3 (15 nm gold) localize to both the internal structures and the limiting
membrane of MIIC.
(D) Analysis of DR3/CFP peptide loading. Lysates of the different transfectants were incubated in SDS-loading buffer and split in two. One
half was boiled at 100°C for 5 min (lanes “b” for boiled) and the other left at room temperature (lane “nb” for nonboiled) before separation by
SDS-PAGE. Proteins were transferred to nitrocellulose and stained with antibody against DRα chain. Free DRα (35 kDa) and DRαβ/CFP
complexes (83 kDa) are indicated. Compact, DR3/CFP-peptide complexes are only detected when cells coexpress DM/YFP and Ii.
(E) Analysis of cell surface-expressed MHC class II complexes. The various transfectants were cell surface iodinated and MHC class II
complexes were immune precipitated. The immune isolates were either boiled in SDS loading buffer (lanes “b”) or left at room temperature
(lanes “nb”) before separation by SDS-PAGE. The position of DRα, DR3β-CFP and the DR3αβ/CFP-peptide complex is indicated. Compact,
DR3/CFP-peptide complexes are only detected at the plasma membrane when cells coexpress DM/YFP and Ii.signal of H2B-CFP and H2B-YFP should be observed in
the final (fully corrected) sensitized emission pictures.
Figure 3A shows a representative example of our ex-
perimental procedure using CLSM-FRET. The H2B-C/
YFP expressing control cells could be easily recognized
by their nuclear fluorescence. Sensitized emission (fur-
ther referred to as ‘FRET’) between DM and DR3 was
only detected in vesicles, as the algorithm used to cor-
rect for leakthrough terms effectively removed both the
DR3 signal at the plasma membrane and the nuclear
H2B-C/YFP fluorescence (Figure 3A, panel FRET).
The efficiency of DR3 interactions with DM was de-
duced from the donor FRET efficiency (ED), the FRET
signal relative to the amount of donor fluorescence,
which is DR3/CFP. A donor FRET efficiency of w5.3%
was detected, far above the minimal efficiency detecta-
ble by this technique (see Supplemental Data). Little
variation was observed between the various MIIC
structures within one cell (Figure 3A, panel ED) and in
cells with different ratios of DR3/CFP versus DM/YFP,
suggesting saturating amounts of DM/YFP for the ca-
talysis of peptide loading of DR3/CFP in these vesicles(Figure S3). This was further visualized by plotting for
each pixel the FRET efficiency versus the DR3/CFP and
DM/YFP intensities (Figure 3E). No correlation was ob-
served between FRET efficiency and the intensity of
CFP and YFP, showing that this represented true in-
teractions rather than accidental collision of both pro-
teins.
GFP and its color variants can be sensitive to the
environment, for example to hydrophobicity and pH
(Tsien, 1998). Because they are situated in acidic vesi-
cles with many membranes, alterations in FRET could
be the result of an altered environment in which the
CFP/YFP molecules reside. As a control, we generated
a stable HEK293 cell line expressing DM/YFP and DO/
CFP. DO is homologous to DR (DOβ shares w75%
amino acid sequence identity with DR3β), but unlike
DR, interacts stably with DM. Consequently, if a change
in FRET efficiency between DO and DM is observed,
this could be the result of an altered environment of the
fluorophores. DO is targeted mainly by DM to MIIC and
is virtually absent from the plasma membrane. DO/CFP
and DM/YFP localized to the same late endocytic,
Immunity
224Figure 2. Dimensions of HLA-DR3/CFP, HLA-
DM/YFP, and FRET
The structures of DR and DM are projected
above a membrane of about 50 Å thick. The
transmembrane regions of both molecules
are undefined and not shown. CFP and YFP
have a barrel shape of 30 × 50 Å with a fluo-
rescent moiety inside. Shown are both the
maximal distance (w80 Å) that can be de-
tected by fluorescence resonance energy
transfer (FRET), and the Förster radius (F0),
the distance at which FRET between CFP
and YFP is half maximal (w50 Å).CD63-containing structures as DM/YFP and DR3/CFP, h
qas shown by CLSM (Figure 3B) and immuno-EM with
anti-GFP antibodies (Figure 3C). As observed before r
l(van Lith et al., 2001), DM/YFP, DO/CFP was mainly lo-
cated on the limiting membrane but also on internal F
Dstructures of characteristic multivesicular/multilamellar
MIIC. These DM/YFP, DO/CFP cells were used as con- M
vtrols in further experiments.
FRET was measured between DO and DM under con- t
Cditions identical to those described for Figure 3A. Effi-
cient FRET was detected between these molecules D
c(Figure 3D). The FRET efficiency for the interaction be-
tween DO and DM was 23.2% (SD = 3.5%) compared [
to 5.3% (SD = 1.5%) observed for DR3 and DM (Figure
3F), and is obviously not affected by acceptor (YFP) n
iconcentrations (Figure 3E). This ratio in FRET efficiency
was determined by both wide field (data not shown) a
oand CLSM-FRET and confirmed by FLIM (Fluorescence
Lifetime Imaging Microscopy) analysis, an alternative s
itechnique to monitor FRET (Bastiaens and Squire,
1999). The lifetime (the average duration of the excited D
state) for the donor CFP is typically 2.7 ns (Vermeer et
al., 2004) but is reduced when energy is transfered to H
DYFP following the same rules for FRET as described
earlier. FLIM offers the advantage that it reports FRET T
in a highly quantitative manner, but as implementedere, lacks confocal sectioning capacity. Also, it re-
uires relatively long sampling times (w12s) to accu-
ately determine the lifetime of the fluorophore (a prob-
em for moving vesicles). Figure 3G shows wide-field
LIM measurements of the DM/YFP and DR3/CFP or
O/CFP cells, cocultured with the H2B-CFP-containing
el JuSo cells in the presence of nocodazole to block
esicle transport. Arrows indicate examples of vesicles
hat were immobile during the measurement. The DR3/
FP lifetime was on average 2.49 ns in the presence of
M/YFP, and 1.52 ns in that of DO/CFP. These values
orrespond to a FRET efficiency ratio of 1:5.6 ([2.7 − 2.49]/
2.7 − 1.52]), similar as detected with CLSM-FRET.
The higher FRET efficiency between DM and DO is
ot surprising because these molecules continuously
nteract, whereas DM will interact transiently with DR3
s long as the class II molecule contains CLIP or an-
ther nonstably binding peptide. Together, these data
how that we have established a cell system to follow
nteractions between DR3 and its dedicated chaperone
M in MIIC of living cells by FRET.
LA-DR3 Interactions with HLA-DM Are Not pH
ependent In Vivo Unless HLA-DO Is Present
he interaction between DM and DR3 is sensitive topH, at least in vitro. DM-mediated peptide exchange on
HLA-DM/-DR Interactions In Vivo
225Figure 3. FRET Measurements
(A) FRET between DR3/CFP and DM/YFP
with internal controls by CLSM. HEK293
cells with DR3/CFP, DM/YFP, and Ii were
cocultured with Mel JuSo cells express-
ing H2B-CFP or H2B-YFP, and FRET was
measured in living cells at 37°C. Nuclear flu-
orescence identifies control cells. After cor-
rection for fluorescent leakthrough (see Sup-
plemental Experimental Procedures), FRET
between DR3 and DM is observed as sensi-
tized emission (panel “FRET”). The efficiency
of interaction is shown in false colors by the
donor FRET efficiency, the FRET signal re-
lated to the amount of donor fluorescence
(panel “ED”). DR3/CFP is located in MIIC and
at the plasma membrane, and DM/YFP only
in MIIC. FRET between these complexes is
solely observed in the endosomal structures.
The relative FRET efficiency values corre-
sponding to the respective colors are indi-
cated.
(B) Intracellular distribution of DO/CFP and
DM/YFP in HEK293 cells. The stable trans-
fectants were methanol fixed, incubated with
anti-CD63 antibodies labeled with Cy5, and
analyzed by CLSM. DM/DO colocalizes with
CD63 in endosomal structures.
(C) Distribution of DO/CFP and DM/YFP in
MIIC. HEK293 cells transfected with the DO/
CFP and DM/YFP were fixed, and sections
were labeled with anti-GFP antibodies be-
fore analysis by immuno-EM. GFP labeling
is observed at the limiting membrane and in
internal structures.
(D) CLSM-FRET with internal controls of liv-
ing HEK293 cells expressing DO/CFP and
DM/YFP. The protocol is described under (A).
High donor FRET efficiency (ED) is observed
between DO and DM in endosomal struc-
tures.
(E) Analysis of FRET efficiency images. From
the images in (A) and (D), CFP, YFP, and
FRET efficiency values were extracted for all
pixels and plotted on the x and y axis,
respectively, with corresponding FRET effi-
ciencies (ED) depicted in the false colors.
The threshold set to exclude background flu-
orescence is indicated with a red line.
(F) Quantification of the donor FRET effi-
ciency (ED). ED observed in endosomal struc-
tures between DR3/CFP and DM/YFP, and
between DO/CFP and DM/YFP was deter-
mined in, respectively, 16 and 11 individual
experiments made on various days.
(G) FLIM measurements of the interactions
between CFP/YFP-labeled DR3 and DM, or
DO and DM in HEK293 cells, cocultured with
H2B-CFP internal controls and treated with-
nocodazole to disrupt vesicle transport.
Fluorophore excited state lifetime decreases upon FRET. Left panel shows wide field CFP fluorescence, right panel shows calculated lifetime
(in ns) in false colors. The average lifetime of CFP in the absence of FRET (2.7 ns) is indicated with a black arrowhead. Only vesicles immobile
during data sampling (w12 s) were considered, of which two examples are indicated in both images by white arrowheads. These vesicles
had a shorter CFP lifetime than the H2B-CFP controls (indicated by asterisk).DR is optimal at pH 4.5 and about 4 times less efficient
at pH 7 (van Ham et al., 2000). Also, DM can only be
coisolated with DR at acidic pH (Sanderson et al.,
1996). Furthermore, prolonged incubation with lysoso-
motropic agents like NH4Cl and chloroquine inhibits
MHC class II antigen presentation (Morrison et al.,
1986). We tested whether neutralization of MIIC by twominutes of chloroquine treatment (Figure S4) affected
the interaction between DM and DR3 in vivo in intact
MIIC, as could now be visualized by FRET. The DM/
YFP, DO/CFP cells were taken to control for potential
influences of pH changes on the fluorophores. Neutral-
ization of acidic structures did not affect FRET effi-
ciency between DM and DO but, surprisingly, neither
Immunity
226Figure 4. Acidic pH and the Interaction between HLA-DR3/CFP and HLA-DM/YFP in the Absence or Presence of HLA-DO
(A) Interaction between DR3/CFP and DM/YFP, or DO/CFP and DM/YFP was measured by CLSM-FRET on HEK293 cells at 37°C, as indicated.
FRET was detected prior to (top) and after neutralization of acidic compartments by 2 min incubation with chloroquine (bottom). The CFP,
YFP, and FRET levels and donor FRET efficiency (ED) were determined (details in Figure 3A). FRET between DR3/CFP and DM/YFP is not
affected by chloroquine treatment, and neither did neutralization affect DO and DM (n > 50 independent measurements).
(B) The interaction between DR3/CFP and DM/YFP becomes pH dependent upon DO expression. The same analysis as in (A) was performed
on the DR3/CFP, DM/YFP and invariant chain-expressing HEK293 transfectants (upper panel), and the same cells overexpressing unlabeled
DO with H2B-mRFP as a transfection marker (lower panel). The H2B-mRFP signal is not shown (see Figure S5). Interaction between DR3/
CFP and DM/YFP is not affected by DO expression at normal acidic pH but is reduced upon neutralization with chloroquine. FRET efficiencies
measured on the identical vesicles prior to and after neutralization are depicted in the bar diagrams with the SD indicated (n > 50 pairwise
measurements).between DR3 and DM (Figure 4A). Only when the pH S
Isensor DO (van Ham et al., 2000) was overexpressed in
the DR3/CFP, DM/YFP cells (Figure S5), a reduction in I
tFRET efficiency between DR3 and DM was observed
upon chloroquine treatment (Figure 4B). Overexpres- o
ssion of DO apparently does not change the relative ori-
entation of DM to DR3, at least not at acidic pH, sug- v
mgesting that DO does not act as a DR mimmick, but
merely as a pH sensor for DM-mediated peptide load- a
cing of DR (van Ham et al., 2000). Still, there is an appar-
ent discrepancy between the in vitro experiments s
awhere DR and DM require acidic pH for activity and the
in vivo FRET data. Possibly, DR3 and DM localize in w
emicrodomains within the MIIC that stabilize their in-
teraction, even under conditions of neutral pH. tpatial Differences within MIIC Affect HLA-DR3
nteractions with HLA-DM
t has been known for over 20 years that long-term
reatment with chloroquine or NH4Cl induces swelling
f lysosomes (Ohkuma and Poole, 1981). We demon-
trate that the membranes needed for swelling are pro-
ided by internal vesicles that fuse back to the limiting
embrane. This is concluded because (1) MIIC swelled
fter chloroquine treatment in our transfectants under
onditions that vesicle transport was blocked (by de-
troying the microtubular network with nocodazole),
nd consequently, input of new membrane material
as prevented (Figure S6, inset). Membranes for the
xpanding limiting membrane can only be supplied by
he internal structures under this condition. (2) Markers
HLA-DM/-DR Interactions In Vivo
227for internal vesicles like CD63 were found at the limiting
membrane after long-term chloroquine treatment (data
not shown). (3) Electron Microscopy (EM) showed that
the swollen MIIC did not contain internal vesicles after
4–6 hr chloroquine treatment because these had sup-
plied the material for the expanding limiting membrane.
Indeed, also DR3/CFP and DM/YFP were located at the
limiting membrane by immuno-EM (Figure 5A) and
CLSM (Figure 5B) in structures without internal vesi-
cles. Thus, long-term chloroquine treatment, which isFigure 5. HLA-DR Interactions with HLA-DM on the Internal Structures of MIIC
(A) Six-hour chloroquine treatment relocalizes DR3/CFP and DM/YFP to the limiting membrane of empty expanded MIIC. HEK293 cells
expressing DR3/CFP, DM/YFP, and Ii were processed for cryo immuno-EM after 6 hr incubation with chloroquine. DR3, 15 nm gold; DM, 10
nm gold. Both proteins localize to the limiting membrane in structures lacking internal vesicles.
(B) DR3/CFP does not interact with DM/YFP at the limiting membrane. HEK293 cells expressing DR3/CFP, DM/YFP, and Ii (upper panel) or
DO/CFP and DM/YFP (middle panel) were analyzed by CLSM-FRET at 37°C after 6 hr of chloroquine treatment. The CFP, YFP, FRET levels,
and donor FRET efficiency (ED) were determined (details in Figure 3A). The lower panel shows the ED in false colors projected on the CFP
signal in white. Whereas DM and DO interact on the limiting membrane, no interaction is observed for DR3 and DM (n > 50 observations).
(C) The structure of partially swollen MIIC after 3 hr chloroquine treatment. HEK293 cells expressing DR3/CFP, DM/YFP and Ii were cultured
for 3 hr in the presence of chloroquine before analysis by cryo immuno-EM. Swollen MIIC are observed still containing internal structures.
DR (15 nm gold) and DM (10 nm gold) are located on both the internal vesicles and limiting membrane.
(D) DR3/CFP interacts with DM/YFP on the internal structures of MIIC. Living HEK293 cells transfected with DR3/CFP, DM/YFP, and Ii (upper
panel) or DO/CFP, DM/YFP (middle panel) were analyzed by CLSM-FRET at 37°C after 3 hr of chloroquine treatment. Panels are organized
identical as in (B). Whereas DM and DO interact on both the internal structures and the limiting membrane, DR3 and DM only interact on the
internal structures (n > 100 observations).known to prevent MHC class II antigen presentation,
appears to alter the architecture of an MIIC structure
by backfusion of the internal vesicles with the limiting
membrane.
We made use of this MIIC remodeling in subsequent
experiments in which the interaction between DM and
DR3 (and between DM and DO as a control) was mea-
sured in cells treated for 6 hr with 200 M chloroquine
(Figure 5B). The interaction (as visualized by CLSM-
FRET) between DM and DO was not affected on
Immunity
228swollen late-endosomal structures (middle panel), t
awhereas DM and DR3 did not interact on the limiting
membrane (the only membrane) of these structures b
k(upper panel). The concentration of DR3/CFP and DM/
YFP does not decrease when the expansion of MIIC is m
athe result of backfusion of internal structures. This im-
plies that the FRET observed in Figure 3A and Figure m
t4A was not caused by coincidental collisions but re-
sulted from more stable interactions. This suggested
that interactions between DR3 and DM in MIIC occur H
exclusively at the internal structures. L
The size of MIIC (~500 nm) is too small to distinguish I
between limiting and internal membranes by light mi- m
croscopy. The swelling of MIIC by chloroquine occurs e
gradually. Therefore, we expected to obtain partially p
swollen structures with internal vesicles 2–3 hr after b
chloroquine addition, providing sufficient spatial resolu- p
tion to distinguish internal and limiting membranes by u
CLSM-FRET. Immuno-EM 3 hr after chloroquine treat- 2
ment showed swollen structures of around 1–2 m with u
internal vesicles still containing DR3 and DM molecules s
(Figure 5C). These MIIC were sufficiently large to re- S
solve internal and limiting membranes by CLSM, and l
FRET between DR3/CFP and DM/YFP in the partially i
swollen MIIC was measured (Figure 5D, upper panel). 2
Although DM and DR3 are both present on the limiting i
and internal membranes, a substantial interaction was H
only observed in the internal structures and not at the a
limiting membrane. To exclude a decrease in DM and/ c
or DR3 concentration due to the addition of mem- S
branes derived from fused vesicles, we repeated the t
experiment on nocodazole treated cells. This gave D
identical results (Figure S6). As a control, DM and DO c
showed FRET at both the limiting and internal mem- (
branes under identical conditions (Figure 5D, middle w
panel). These data indicate that MIIC are not homogen- i
eous structures but that they contain various subdo- D
mains that allow a productive interaction between DM c
and DR3 only on the internal structures but not the lim- C
iting membrane. v
m
CInhibition of Formation of Internal Structures
Prevents the Interaction between HLA-DR3 n
tand HLA-DM
The PI 3-kinase VPS34 is required to initiate a cascade f
oof events resulting in recruitment of ESCRT complexes
and ultimately formation of internal structures within c
Dmultivesicular bodies (Katzmann et al., 2002). Inhibition
of hVPS34, either genetically or with chemical inhibitors i
f(Fernandez-Borja et al., 1999), results in swollen struc-
tures only containing a limiting membrane. Inhibition of 7
uhVPS34 would thus be an alternative to recruit DR3/
CFP and DM/YFP to the limiting membrane. However, p
Sunlike the situation for chloroquine, the structures re-
main acidic (Figure S7). An RNAi construct targeting p
thVPS34 was cotransfected with mRFP in HEK293 cells
expressing DR3/CFP, DM/YFP, and the invariant chain, C
tas well as in cells expressing DO/CFP and DM/YFP as
a control. Only mRFP-positive cells were analyzed for c
tswollen structures, and FRET and donor FRET effi-
ciency was determined (Figure 6). Whereas DM/YFP Y
tand DO/CFP showed FRET with normal efficiency, no
FRET was detected between DR/CFP and DM/YFP at Fhe limiting membrane of these swollen structures,
nalogous to the situation where MIIC was expanded
y chloroquine (Figure 5). In conclusion, two treatments
nown to inhibit antigen presentation by MHC class II
olecules (Allen and Unanue, 1984; Song et al., 1997)
lso induce localization of DR3 and DM to the limiting
embrane of MIIC, where the interaction between
hese two proteins is prevented (Figure 6).
LA-DR3 Interactions with HLA-DM and Peptide
oading on Phagosomal Membranes
f DR3 and DM fail to interact efficiently on limiting
embranes, this may explain examples of immune
scape observed under physiological conditions. In
articular, bacterial pathogens like Mycobacterium tu-
erculosis and Salmonella typhimurium survive and
ropagate in acidified, self-induced phagosomes often
nnoticed by the immune system (Ramachandra et al.,
001). Phagosomes contain a limiting membrane only,
nless the pathogen is killed. Recently, it has been
hown that Salmonella secretes the PIP2-phosphatase
opB into the cytoplasm of infected cells that hydro-
yzes a downstream product of hVPS34 (PI(3,5)P2), thus
nducing phagosome formation (Hernandez et al.,
004). Hence, is the interaction between DR3 and DM
nhibited at the phagosomal membrane? We infected
EK293 cells expressing DR3/CFP, DM/YFP and invari-
nt chain with Salmonella for 4 hr and processed the
ells for immuno-EM (Figure 7A, left panel). Intracellular
almonella was found in a typical phagosome (termed
he Salmonella-containing vacuole or SCV), containing
R3 and DM at the limiting membrane. No internal vesi-
les were found unless the bacterium was degraded
Figure 7A, right panel). Conventional, unaffected MIIC
ere also found in the same cell (Figure 7A, left panel
nsert). Next, we determined whether FRET between
R3/CFP and DM/YFP could be detected in SCV. As a
ontrol, we measured FRET between DM/YFP and DO/
FP on the same compartment. To allow simultaneous
isualization of the intracellular bacteria, we generated
RFP-expressing Salmonellae. Figure 7B shows
LSM-FRET images of SCV and MIIC after 4 hr Salmo-
ella infection in cells expressing DM and DO. The in-
eraction between DO/CFP and DM/YFP was not af-
ected on the phagosomal membrane. The interaction
f DM and DR3 on SCV is shown in Figure 7C. To ex-
lude the possibility that FRET between DR3/CFP and
M/YFP was not observed because their fluorescent
ntensities fell below the treshold set for background
luorescence, we analyzed the data in Figures 7B and
C by the same 2D-intensity plot approach used in Fig-
re 3E. In addition, the CFP and YFP intensities of the
ixels corresponding to the limiting membrane of the
CV where FRET was not detected are indicated in pur-
le (Figure 7D). The limiting membrane of SCV con-
ained hardly any pixels without FRET between DO/
FP and DM/YFP (resulting in only few purple dots in
he middle panel). In contrast, pixels lacking FRET effi-
iency at the SCV membrane were abundantly found in
he DR3/CFP, DM/YFP cells. The intensities of CFP and
FP in the majority of these SCV pixels corresponded
o those found for MIIC in the same cell with positive
RET efficiencies. This analysis was repeated by con-
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the Interaction of HLA-DR3 with HLA-DM
HEK293 cells expressing DR3/CFP, DM/YFP
and Ii, or DO/CFP and DM/YFP were trans-
fected with two constructs encoding the
RNAi for hVPS34 and soluble mRFP, respec-
tively. After 72 hr, living cells expressing
mRFP (not shown) with swollen MIIC were
analyzed. A zoom-in of an expanded struc-
ture is shown. The CFP signal, YFP signal,
FRET, and donorFRET efficiency (ED) mea-
surements are indicated (details in Figure
3A). The lower panel shows the ED projected
in false colors on the CFP signal in white.
Whereas both DR3/CFP and DM/YFP are
present at the limiting membrane of the ex-
panded MIIC, they do not interact (n > 50
independent measurements).sidering the poisson-distributed noise for the calcu-
lated ED per pixel (Figure S8). Collectively, these data
show an equally efficient interaction between DO and
DM in MIIC and SCV, whereas the interaction between
DR3 and DM was only observed in the MIIC and not
the SCV membrane. Thus, within the same cell, two
types of MHC class II-containing compartments were
found: MIIC, where DM and DR3 could engage in anti-
gen loading, and SCV, where DM and DR3 were pre-
vented from interacting. MIIC vesicles showed con-
tinuous kiss-and-run type of contacts with the SCV
(data not shown) but no DM/DR3 interaction was ob-
served on the limiting membrane in more than 60% of
the SCV (41 negative, 25 positive SCVs, n = 66). When
Salmonella was intracellularly degraded, internal struc-
tures reappeared (Figure 7A, right panel), probably
leading to some SCVs with detectable FRET between
DM and DR3. Thus, the interaction between DR3 and
DM was obstructed in intact phagosomal structures,
similar to the situation in swollen MIIC, apparently be-
cause the microenvironment of internal endosomal
membranes is a prerequisite for this interaction.
Is the loading of MHC class II molecules in SCV af-
fected, as would be predicted from the FRET data?
HEK293 cells expressing DR3/CFP, DM/YFP, and the in-
variant chain were infected with Salmonella for 4 hr be-
fore subcellular fractionation. Twenty percent of each
fraction was used to measure β-hexosaminidase activ-
ity to position the late endosomes and lysosomes (Fig-ure 7E, upper panel). The rest was incubated in SDS
sample buffer at room temperature before separation
by SDS-PAGE and Western blotting. This procedure
should allow detection of compact type, SDS-stable,
peptide-loaded DR3/CFP molecules (Germain and
Hendrix, 1991). The nitrocellulose filter was probed se-
quentially with antibodies directed against the DRα
chain and DR3αβ-peptide complex, against GFP, MHC
class I molecules, and against a 30 kDa Salmonella pro-
tein. The position of the various proteins is given in the
compilation (Figure 7E, lower panel). MHC class I marks
the plasma membrane and ER (fraction 6,7), β-hexo-
saminidase and DMα-YFP the MIIC (fractions 5,6), and
the Salmonella protein the SCV (fractions 9,10). SCV
contained both DM/YFP and DR3/CFP, as was also
shown by CLSM and EM (Figures 7A–7C). Still, whereas
a large portion of DR3/CFP was in a compact state in
the plasma membrane and MIIC-containing fractions,
hardly any peptide-loaded DR3 molecules were ob-
served in SCV (compare lanes 5 and 9 in Figure 7E).
Peptide loading of DR3 in SCV was apparently very in-
efficient, corresponding with the poor interaction ob-
served between DM and DR3 on the limiting mem-
branes of SCV and MIIC.
Discussion
The MIIC was defined in 1991 as a late endosomal
compartment with a multilamellar morphology contain-
Immunity
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(A) Salmonella containing vacuoles (SCV), MIIC and internal vesicles. HEK293 cells expressing DR3/CFP, DM/YFP and Ii were infected with
Salmonella for 4 hr prior to fixation and processing for immuno-EM. Left panel shows two SCV that have considerably expanded (asterices).
The SCV label for DR (15 nm gold) and DM (10 nm gold) at the limiting membrane, and lack internal structures. Inset: higher magnification of
MIIC labeling for DR and DM within the same section. Right panel: formation of internal structures upon Salmonella death. The typical dense
structures represent remnants of Salmonella in a structure labeling for DR and DM. Note the appearance of internal structures.
(B) Interactions between DO/CFP and DM/YFP on SCV. HEK293 cells expressing DO/CFP and DM/YFP were infected by mRFP expressing
Salmonella for 4 hr before imaging by CLSM-FRET at 37°C. DO/CFP, DM/YFP and mRFP-Salmonella can be simultaneously detected, as
indicated. The cell boundary and the nucleus are drawn in the image showing the location of the bacterium. The expanded SCV are detectable
in the CFP and YFP channels. Donor FRET efficiency (ED) is shown in false colors with the corresponding values. The efficiency of interaction
between DO and DM is not affected on the Salmonella-containing vacuoles. Inset: magnification of the SCV region depicted in the ED picture
with a projection of Salmonella in pink (n > 50 observations).
(C) DR3/CFP and DM/YFP fail to interact in mRFP-expressing Salmonella containing vacuoles. HEK293 cells expressing DR3/CFP, DM/YFP
and Ii were infected with mRFP-Salmonella for 4 hr before analysis by CLSM-FRET at 37°C. The various fluorophores were detected as in B.
mRFP-Salmonella containing phagosomes with DR3/CFP and DM/YFP did not show FRET in contrast to normal MIIC in the same cell. (n >
60 observations). Note that a number of these normal MIIC are located close to the SCV.
(D) Analysis of FRET efficiency images. The images in (B) and (C) were analyzed as described in Figure 3E. The gray region depicts the
treshold settings in these experiments. The CFP and YFP intensities of the pixels corresponding to the limiting membrane of the SCV, where
no FRET was detected, are indicated in purple in the DO/CFP, DM/YFP (top), and the DR3/CFP and DM/YFP (bottom) plots. The intensities
of DR3/CFP and DM/YFP on the SCV are comparable to MIIC within the same cell where normal FRET is measured.
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(E) Peptide loading of DR3/CFP in subcellular fractions. HEK293 cells expressing DR3/CFP, DM/YFP, and Ii were infected with Salmonella for
4 hr, followed by subcellular fractionation (fraction 1–10). After fractionation, the vesicles were pelleted, incubated in SDS-loading buffer, and
analyzed by SDS-PAGE and Westernblotting with various antibodies (bottom panel). The position of the various proteins is indicated. Fraction
5–6 showed β-hexosaminidase activity (top panel), and corresponded to MIIC. Fraction 6,7, marked by MHC class I, contained the plasma
membrane (PM/ER). The SCV ran at a high density and contained a 30 kDa protein (fraction 9,10). Right lane: longer exposure of fraction 10.
The conditions used, separated unstable (DRα, 35 kDa) from compact DR3/CFP molecules (DRαβ-CFP, 85 kDa). Compact DR/CFP molecules
were located in the MIIC and PM/ER fractions, but were virtually absent in the SCV fractions.ing MHC class II molecules (Peters et al., 1991). Since
then, a number of factors have been defined, notably
cathepsins (Honey and Rudensky, 2003) and DM (Den-
zin and Cresswell, 1995; Sherman et al., 1995), required
for successful antigen loading of MHC class II mole-
cules. The localization of DM to MIIC defined it as the
major site for antigen loading of MHC class II molecules
(Sanderson et al., 1994). The interaction between DM
and MHC class II molecules has been shown in vitro
and by coisolation (Doebele et al., 2000; Sanderson et
al., 1996; Ullrich et al., 1997). Critical for this interaction
is acidic pH, as expected for a late-endosomal chaper-
one. How DM and DR interact in living cells has been
unclear. For this reason, we generated cells expressing
DR3 conjugated to CFP and YFP-labeled DM. DR3/CFP
required the invariant chain for efficient release from
the ER and transport to MIIC. The CFP/YFP modifica-
tions did not block peptide loading of DR3 because
compact, SDS-stable, DR3/CFP molecules were
formed with the support of DM/YFP. Next, we studied
the interaction between DR3 and DM in living cells by
FRET analysis. As a control, we used a cell line ex-
pressing DM/YFP and DO/CFP. DO is very similar to
DR3 but stably interacts with DM. Because of their high
similarity, DO may mimic DR for DM molecules. How-
ever, since overexpressed DO does not affect the FRET
efficiency between DR3 and DM, this is unlikely. DO is
apparently not a competitor for DR3 binding to DM but
probably binds at another site thus affecting the (pH-
dependent) chaperoning activity of DM.
The internal membranes of the MIIC have a different
protein and lipid composition than the limiting mem-
brane. DM and DR can be found in both endosomal
subcompartments, albeit in variable amounts (Kleij-
meer et al., 1997). We have investigated DR/DM in-
teractions in the MIIC by FRET. Like their untagged
counterparts, the DR3/CFP and DM/YFP molecules lo-
calized to both the internal structures and the limiting
membrane, but FRET between these molecules was
only seen on the internal structures. In order to optically
separate internal and limiting membranes, the MIIC
was swollen by chloroquine treatment. Chloroquine in-
duces the fusion of internal structures with the limiting
membrane, which subsequently expands at the cost of
the internal structures. Long-term treatment with chlo-
roquine completely depleted the internal structures and
DR3 and DM resided at the limiting membrane where
they failed to interact. Chloroquine treatment is a com-
mon way to inhibit (most) MHC class II responses. This
could be the result of decreased antigen degradation
by lysosomal proteases due to neutralization (although
most cathepsins are active at neutral pH), less efficient
support by DM (yet we show that the interaction withthe result of repositioning DM and DR3 to the limiting
membrane where they do not interact.
How is the interaction between DM and DR3 sup-
ported at the internal structures? Obvious candidates
are the tetraspans CD63 and CD82, given their almost
exclusive location in the internal structures and their
interaction with MHC class II and DM (Escola et al.,
1998; Hammond et al., 1998). It has been suggested
that microdomain clusters of DR/DM and the tetra-
spans could have different peptide loading properties
(Kropshofer et al., 2002). However, the tetraspans CD63
and CD82 are also relocated to the limiting membrane
following chloroquine treatment (not shown) where DR3
and DM do not interact. Thus, the tetraspans CD63 and
CD82 are not sufficient, if at all required, for stable DR3/
DM interactions. Whether other proteins or lipids are
involved in the formation of a putative “MHC class II
loading microdomain” inside the MIIC, is as yet unclear.
Phagosomes are endosomal structures where intra-
cellular bacteria survive and even propagate. Morpho-
logically, these structures resemble a swollen MIIC, and
can be considered a limiting membrane around the
bacterium. Various studies describe the effect of intra-
cellular bacteria on antigen presentation. CD4+ T cells
can be easily isolated after most bacterial infections,
but it is unclear whether this is a response to a killed
bacterium or a viable one. In vitro T cell assays yield
mixed conclusions (Zur Lage et al., 2003). T cell re-
sponses against other antigens coincubated with the
bacterium are usually not affected, although some in-
fections can reduce or inhibit antigen presentation by
MHC class II (Flynn and Chan, 2003). Whereas various
bacteria neutralize phagosomes, Salmonella allows
acidification, which is even required for the secretion of
effector proteins (Beuzon et al., 1999).
Salmonella apparently forms phagosomes by secret-
ing a PIP2-phosphatase, SopB, thus inactivating the
hVPS34-ESCRT system of internal vesicle formation
(Hernandez et al., 2004). Likewise, M. tuberculosis toxin
directly inactivates hVPS34 (Vergne et al., 2003). Down-
regulation of hVPS34 by RNAi induced expanded MIIC
and prevented the interaction between DR3/CFP and
DM/YFP on the limiting membrane. This also inhibits
antigen presentation by MHC Class II (Song et al.,
1997). In addition, the expression of DM/YFP and DR3/
CFP at the SCV was lower. Whether this is the conse-
quence of the altered interactions is unclear.
Still, the effect on DM/DR interactions is local. In the
same cells, “normal” MIIC were found where DM and
DR3 associated both in biochemical and FRET assays.
Fractionation studies indicated that MHC class II load-
ing occurs in MIIC structures but poorly in SCV. This
suggests that intracellularly growing bacteria prevent
Immunity
232Gmation of the typical architecture found in MIIC. At pre-
ssent, it is unclear whether this is just the result of their
Cphysical size or a situation actively maintained by the
bbacterium. In approximately 35% of the cases, we de-
c
tected FRET between DM and DR3 in Salmonella con- s
taining phagosomes, which could be the result of death
C
and disintegration of the bacterium; conditions where f
internal DM- and DR3-containing structures reappear J
in the SCV. However, surviving and viable intracellular C
pathogens will remain undetected by CD4+ T cells as c
long as they prevent leakage of antigens into conven- D
tional MIIC. This local immune evasion may explain why c
lother antigen presenting molecules have been devel-
oped, the CD1 family, to present antigens in a manner D
Cindependent of DM (Vincent et al., 2003).
IWe have visualized the interaction of DM and DR3 in
Dliving cells by FRET and have defined an MHC class II
(loading microdomain. DR3 interacted with its chaper-
m
one DM only on the internal membranes within an MIIC.
EConsequently, structures containing only a limiting
O
membrane will not support efficient interactions be- t
tween these two molecules, a situation observed in e
phagosomes. By preventing the formation of the con- 2
ventional architecture of MIIC, Salmonella excludes the F
vcreation of MHC class II-loading microdomains, result-
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